Inspire Investing’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.97M Buy
15,972
+3,471
+28% +$2.23M 0.52% 32
2025
Q4
$8.46M Buy
12,501
+4,033
+48% +$2.75M 0.76% 18
2025
Q3
$5.41M Buy
8,468
+6
+0.1% +$3.64K 0.53% 30
2025
Q2
$4.54M Sell
8,462
-5,115
-38% -$2.45M 0.49% 36
2025
Q1
$5.7M Buy
13,577
+3,472
+34% +$1.51M 0.68% 24
2024
Q4
$4.18M Sell
10,105
-173
-2% -$75.9K 0.47% 41
2024
Q3
$5.19M Sell
10,278
-354
-3% -$172K 0.53% 33
2024
Q2
$5.18M Sell
10,632
-1,406
-12% -$706K 0.6% 26
2024
Q1
$6.5M Buy
12,038
+1,067
+10% +$583K 0.67% 26
2023
Q4
$6.09M Sell
10,971
-570
-5% -$268K 0.67% 22
2023
Q3
$5.05M Sell
11,541
-175
-1% -$87.3K 0.64% 25
2023
Q2
$5.88M Buy
11,716
+854
+8% +$409K 0.71% 22
2023
Q1
$5.43M Buy
10,862
+758
+8% +$363K 0.69% 26
2022
Q4
$4.12M Sell
10,104
-1,297
-11% -$503K 0.53% 34
2022
Q3
$3.71M Sell
11,401
-408
-3% -$150K 0.52% 31
2022
Q2
$4.14M Sell
11,809
-304
-3% -$124K 0.55% 31
2022
Q1
$6.63M Sell
12,113
-1,532
-11% -$806K 0.77% 19
2021
Q4
$8.98M Buy
13,645
+1,642
+14% +$1.03M 1.03% 14
2021
Q3
$7.46M Buy
12,003
+9,482
+376% +$6.37M 0.94% 14
2021
Q2
$1.59M Buy
2,521
+523
+26% +$289K 0.21% 100
2021
Q1
$978K Buy
1,998
+460
+30% +$230K 0.15% 133
2020
Q4
$768K Buy
1,538
+605
+65% +$271K 0.17% 111
2020
Q3
$367K Sell
933
-279
-23% -$103K 0.1% 195
2020
Q2
$400K Sell
1,212
-580
-32% -$168K 0.14% 122
2020
Q1
$434K Sell
1,792
-623
-26% -$163K 0.17% 111
2019
Q4
$631K Buy
2,415
+271
+13% +$71.4K 0.23% 125
2019
Q3
$583K Buy
2,144
+18
+0.8% +$5.01K 0.22% 129
2019
Q2
$585K Sell
2,126
-328
-13% -$80.8K 0.25% 111
2019
Q1
$549K Buy
2,454
+600
+32% +$124K 0.25% 100
2018
Q4
$345K Buy
1,854
+212
+13% +$43.5K 0.23% 105
2018
Q3
$410K Sell
1,642
-73
-4% -$17.7K 0.25% 87
2018
Q2
$374K Sell
1,715
-31
-2% -$6.39K 0.27% 85
2018
Q1
$334K Buy
1,746
+196
+13% +$36.2K 0.34% 31
2017
Q4
$242K Buy
+1,550
New +$244K 0.21% 46

Other funds holding IDXX

Inspire Investing's IDXX Position: Q1 2026 in Review

Inspire Investing increased its Idexx Laboratories (IDXX) stake by 28% in Q1 2026, buying an estimated $2.23M and bringing the position to 15,972 shares worth $8.97M. The position accounts for 0.52% of the portfolio, ranked #32.

Inspire Investing first reported a position in IDXX in Q4 2017 and has held it in 34 quarters since. The position peaked at $8.98M in Q4 2021. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Inspire Investing held 15,972 shares of Idexx Laboratories worth $8.97M as of Q1 2026.
  • Inspire Investing bought 3,471 Idexx Laboratories shares in Q1 2026, an estimated $2.23M.
  • Idexx Laboratories made up 0.52% of Inspire Investing's portfolio in Q1 2026, its #32 holding.
  • Inspire Investing first reported a position in Idexx Laboratories in Q4 2017 and has held it in 34 quarters since.
  • Inspire Investing's Idexx Laboratories position peaked at $8.98M in Q4 2021.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.